Thomson Reuters
This mechanism of action prevents the dimerization of these two proteins and blocks the binding of NRG1 to HER3, in turn reducing cell proliferation and promoting the immune systems cancer-killing activity

RSV surveillance & research, Centers for Disease Control and Prevention (2023) FDA approves first respiratory syncytial virus (RSV) vaccine, Food and Drug Administration (2023) Cost and coverage, GSK Respiratory syncytial virus (RSV) shot, Medicare.gov ACIP vaccine recommendations and guidelines, Centers for Disease Control and Prevention (2023) Explaining the prescription drug provisions in the Inflation Reduction Act, KFF (2023) Coverage, GSK Medicare Part D in 2024: A first look at prescription drug plan availability, premiums, and cost-sharing, KFF (2023) Medicaid eligibility, Medicaid.gov State profiles, Medicaid.gov Copay relief, Patient Advocate Foundation How we help, PAN Foundation State pharmaceutical assistance programs, National Conference of State Legislatures Abrysvo, Food and Drug Administration (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

At the same time, the drug development horizon is full of promising directions: oral formulations, multi-agonists, longer-acting molecules, and the emergence of biomarkers to personalize therapy